BamSEC and AlphaSense Join Forces
Learn More

ProMIS Neurosciences Inc.

NASDAQ: PMN    
Share price (1/3/25): $1.04    
Market cap (1/3/25): $31.1 million

Articles of Incorporation Filter

EX-3.1
from 8-K 11 pages ProMIS Neurosciences Inc. Corporation Name / Dénomination Sociale
12/34/56
EX-3.3
from 8-K 7 pages ​ By-Law No. 2 a By-Law Relating to the Nomination of Directors ProMIS Neurosciences Inc
12/34/56
EX-3.2
from 8-K 26 pages Amended and Restated ​ By-Law No. 1 ​ of ​ ProMIS Nueroscienes Inc. ​
12/34/56
EX-3.1
from 8-K 8 pages Articles of Continuance Business Corporations Act 1. Corporation Name ProMIS Neurosciences Inc. 2. Date of Incorporation/Amalgamation September 21, 2005 3. Name of Jurisdiction the Corporation Is Leaving Canada - Federal 4.the Continuance Was Authorized by Home Jurisdiction on June 29, 2023 5.the Corporation Is Continued in Ontario Under the Name ProMIS Neurosciences Inc. 6. Registered Office Address 181 Bay Street, 4400, Toronto, Ontario, Canada, M5j 2t3 7. Number of Directors ​ ​ Minimum/Maximum Min 3 / Max 10 ​ ​ the Endorsed Articles of Continuance Are Not Complete Without the Certificate of Continuance. Certified a True Copy of the Record of the Ministry of Public and Business Service Delivery. ​ ​ Director/Registrar, Ministry of Public and Business Service Delivery Page 1 of 7 ​ Bca - Articles of Continuance - ProMIS Neurosciences Inc. - Ocn:1678696 - July 13, 2023 8.the Director(s) Is/Are
12/34/56
EX-3.1.3
from 10-12B/A 3 pages Misrepresentation Constitutes an Offence And, on Summary Conviction, a Person Is Liable to a Fine Not Exceeding $5000 or to Imprisonment for a Term Not Exceeding Six Months or Both (Subsection 250 (1) of the Cbca). Faire Une Fausse Déclaration Constitue Une Infraction Et Son Auteur, Sur Déclaration De Culpabilité Par Procédure Sommaire, Est Passible D’une Amende Maximale De 5 000 $ Et D’un Emprisonnement Maximal De Six Mois, Ou L’une De Ces Peines (Paragraphe 250(1) De La Lcsa). You Are Providing Information Required by the Cbca. Note That Both the Cbca and the Privacy Act Allow This Information to Be Disclosed to the Public. It Will Be Stored in Personal Information Bank Number Ic/Ppu-049
12/34/56
EX-3.2.1
from 10-12B 7 pages By-Law No. 2 a By-Law Relating to the Nomination of Directors Amorfix Life Sciences Ltd
12/34/56
EX-3.2
from 10-12B 28 pages Amended and Restated By-Law No. 1 of ProMIS Nueroscienes Inc
12/34/56
EX-3.1.2
from 10-12B 6 pages Schedule a to Articles of Amendment of ProMIS Neurosciences Inc
12/34/56
EX-3.1.1
from 10-12B 2 pages Certificate of Amendment Certificat De Modification Canada Business Corporations Act Loi Canadienne Sur Les Sociètès Par Actions ProMIS Neurosciences Inc. Corporate Name / Dènomination Sociale 432461-7 Corporation Number / Numèro De Sociètè
12/34/56
EX-3.1
from 10-12B 4 pages Canada Business Corporations Act Loi Canadienne Sur Les Sociètès Par Actions Form 9 Articles of Amalgamation (Section 185) Formule 9 Statuts De Fusion
12/34/56
EX-3.2(1)
from DRS 7 pages By-Law No. 2 a By-Law Relating to the Nomination of Directors Amorfix Life Sciences Ltd
12/34/56
EX-3.2
from DRS 30 pages The Following Is an Extract of the Minutes of the Annual Meeting of Shareholders of ProMIS Neurosciences Inc. Dated June 28, 2017 Held at 9:00 Am. Approval of Amendments to the By-Laws “Be It Resolved That: 1. the Following Amendments to By-Laws of the Corporation Are Hereby Confirmed: (A) Section 10.4 Is Deleted and Replaced With the Following
12/34/56
EX-3.1(1)
from DRS 2 pages Certificate of Amendment Certificat De Modification Canada Business Corporations Act Loi Canadienne Sur Les Sociètès Par Actions ProMIS Neurosciences Inc. Corporate Name / Dènomination Sociale 432461-7 Corporation Number / Numèro De Sociètè
12/34/56
EX-3.1
from DRS 4 pages Canada Business Corporations Act Loi Canadienne Sur Les Sociètès Par Actions Form 9 Articles of Amalgamation (Section 185) Formule 9 Statuts De Fusion
12/34/56